There are 3 papers on HPV 16/18 positivity in aging research: 3 observational studies in people.
3 papers study it1 more mentions it1 finding
2 new papers in 30 daysSee all 4 papers on HPV 16/18 positivity
“Three-year cumulative CIN2+ risk was 20.9% (15.2-28.1) for HPV 16/18-positive women, 6.6% (4.9-8.9) for other types, and 0.1% (0.04-0.2) for HPV-negative women.”
- Humans3
Associations
1Cervical intraepithelial neoplasia grade 2 or worse
upin humans1
1 study
Cervical intraepithelial neoplasia grade 2 or worse
upin humans1
HPV 16/18 positivity predicts cervical intraepithelial neoplasia grade 2 or worse in humans (normal cytology) (Three-year cumulative risk: 20.9% (95% CI 15.2–28.1) for HPV 16/18-positive women versus 0.1% (0.04–0.2) for HPV-negative women).
“Three-year cumulative CIN2+ risk was 20.9% (15.2-28.1) for HPV 16/18-positive women, 6.6% (4.9-8.9) for other types, and 0.1% (0.04-0.2) for HPV-negative women.”
Humansnormal cytology3 yearsfemalesn = 6,679
Journal of clinical microbiology
Latest
4 papers in 12 monthsEuropean Journal of Obstetrics, Gynecology, and Reproductive Biology
Performance of HPV-test screening in young women: Results from a population-based study in Brazil
Cohort study of 2,742 peopleBiomarkers
Journal of Clinical Microbiology
HPV testing with 16/18 genotyping for risk stratification among women with normal cytology: a multicenter prospective cohort study from China
Cohort study of 6,679 peopleBiomarkers
BMJ Open Quality
Implementation of self-collected cervical screening in an under-screened, culturally and linguistically diverse antenatal population: a quality improvement study
Non-randomized trial in 5,190 peopleInterventions